Akero Therapeutics (AKRO)
(Delayed Data from NSDQ)
$25.17 USD
-1.18 (-4.48%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $25.16 -0.01 (-0.04%) 6:58 PM ET
2-Buy of 5 2
D Value F Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/9/24 |
---|---|
Current Quarter | -0.90 |
EPS Last Quarter | -0.90 |
Last EPS Surprise | 0.00% |
ABR | 1.18 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -3.82 |
Next Year | -4.29 |
EPS (TTM) | -3.20 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.90 | -0.97 | -3.82 | -4.29 |
# of Estimates | 5 | 4 | 7 | 5 |
Most Recent Consensus | -0.89 | -0.94 | -3.68 | -4.02 |
High Estimate | -0.82 | -0.87 | -3.48 | -3.92 |
Low Estimate | -0.95 | -1.02 | -4.24 | -4.82 |
Year ago EPS | -0.60 | -0.71 | -2.89 | -3.82 |
Year over Year Growth Est. | -50.00% | -36.62% | -32.18% | -12.29% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 1 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.90 | -0.97 | -3.82 | -4.29 |
7 Days Ago | -0.90 | -0.97 | -3.82 | -4.29 |
30 Days Ago | -0.90 | -0.97 | -3.82 | -4.29 |
60 Days Ago | -0.90 | -0.97 | -3.87 | -4.29 |
90 Days Ago | -1.01 | -1.06 | -3.93 | -4.42 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.90 | -0.97 | -3.82 | -4.29 |
Zacks Consensus Estimate | -0.90 | -0.97 | -3.82 | -4.29 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.90 | -0.99 | -0.71 | -0.60 | NA |
Estimate | -0.90 | -0.82 | -0.69 | -0.62 | NA |
Difference | 0.00 | -0.17 | -0.02 | 0.02 | -0.04 |
Surprise | 0.00% | -20.73% | -2.90% | 3.23% | -5.10% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more